EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Mosaic KRAS Mutation in Schimmelpenning–Feuerstein–Mims Syndrome With Overlapping Oculoectodermal Syndrome and Encephalocraniocutaneous Lipomatosis Features

Hyvönen Hanna iD, Kettunen Kaisa, Avela Kristiina, Kivirikko Sirpa, Jeskanen Leila, Suominen Sinikka, Salminen Päivi, Hannula-Jouppi Katariina

Pediatric Dermatology · 2025

DOI: 10.1111/pde.15820 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Pediatric Dermatology, 2025. Verfasst von Hyvönen Hanna und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Allergology, ERN-Skin Reference Center, Skin and Allergy Hospital, University of Helsinki and Helsinki University Hospi…. Hauptthemen laut MEDLINE: Ectodermal Dysplasia, Lipomatosis, Neurocutaneous Syndromes, Proto-Oncogene Proteins p21(ras). Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: the State Funding for University-level Health Research..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We report a patient with clinically confirmed Schimmelpenning–Feuerstein–Mims (SFM) syndrome but many overlapping features with oculoectodermal syndrome (OES) and encephalocraniocutaneous lipomatosis (ECCL). Whole exome sequencing revealed a mosaic KRAS c.436G>A, p.(Ala146Thr) mutation, previously identified in three OES and ECCL patients. These findings corroborate the evidence of SFM syndrome being a mosaic RAS opathy, broaden the phenotypic spectrum of oculocutaneous mosaic RAS opathies, and indicate SFM syndrome as a continuum of the OES–ECCL disorder spectrum.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ectodermal DysplasiaLipomatosisNeurocutaneous SyndromesProto-Oncogene Proteins p21(ras)HumansExome SequencingMosaicismMutationEye Diseases

Stichwörter der Autor:innen

dermatologygenotypemosaicismmutationphenotype

Substanzen

KRAS protein, humanProto-Oncogene Proteins p21(ras)

Autor:innen und Institutionen

  • Department of Dermatology and Allergology, ERN-Skin Reference Center, Skin and Allergy Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Laboratory of Genetics, Division of Genetics and Clinical Pharmacology, HUS Diagnostic Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Department of Clinical Genetics, University of Helsinki and Helsinki University Hospital. Department of Medical Genetics, University of Turku and Turku University Hospital, Helsinki, Finland.
  • Department of Clinical Genetics, ERN Ithaca, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Department of Plastic Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Department of Pediatric Surgery, HUS Rare Diseases Center, VASCERN VASCA European Reference Centre, New Children's Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

ORCID-Profile: Hyvönen Hanna

Förderung

  • the State Funding for University-level Health Research.

Zitieren

APA

Hanna, H., Kaisa, K., Kristiina, A., Sirpa, K., Leila, J., Sinikka, S., Päivi, S., & Katariina, H. J. (2025). Mosaic KRAS Mutation in Schimmelpenning–Feuerstein–Mims Syndrome With Overlapping Oculoectodermal Syndrome and Encephalocraniocutaneous Lipomatosis Features. Pediatric Dermatology. https://doi.org/10.1111/pde.15820

Vancouver

Hanna H, Kaisa K, Kristiina A, Sirpa K, Leila J, Sinikka S, et al. Mosaic KRAS Mutation in Schimmelpenning–Feuerstein–Mims Syndrome With Overlapping Oculoectodermal Syndrome and Encephalocraniocutaneous Lipomatosis Features. Pediatric Dermatology. 2025. doi:10.1111/pde.15820

BibTeX
@article{Hanna2025,
  author = {Hanna, Hyvönen and Kaisa, Kettunen and Kristiina, Avela and Sirpa, Kivirikko and Leila, Jeskanen and Sinikka, Suominen and Päivi, Salminen and Katariina, Hannula-Jouppi},
  title = {Mosaic KRAS Mutation in Schimmelpenning–Feuerstein–Mims Syndrome With Overlapping Oculoectodermal Syndrome and Encephalocraniocutaneous Lipomatosis Features},
  journal = {Pediatric Dermatology},
  year = {2025},
  doi = {10.1111/pde.15820}
}
Kostenlos starten →